Humacyte Inc Sustainability Reports
Humacyte, Inc. develops and manufactures off-the-shelf, universally implantable bioengineered human tissues and organ systems. The company's proprietary platform creates acellular tissues designed to treat a wide range of diseases, injuries, and chronic conditions.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00XPPT7T6
2 reports from 2021 to 2024
Company Profile
Humacyte, Inc. develops and manufactures off-the-shelf, universally implantable bioengineered human tissues and organ systems. The company's proprietary platform creates acellular tissues designed to treat a wide range of diseases, injuries, and chronic conditions.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
